Literature DB >> 24554256

[Sjögren's syndrome].

T Witte1.   

Abstract

Sjögren's syndrome is an autoimmune disease characterized by lymphocytic infiltration of the tear and salivary glands leading to dryness of the mouth and eyes. The awareness that extraglandular manifestations, such as polyneuropathy, arthritis or recurrent airway infections may indicate Sjögren's syndrome is important. In the diagnostic procedure, the tear and saliva production and antibodies against Sjögren's syndrome A (SS-A) and SS-B should be measured. A salivary gland biopsy should be performed when the diagnosis is not still clear. The therapy of oral and ocular dryness is mainly symptomatic whereas the treatment of extraglandular manifestations is based on experience with treatment of these manifestations in systemic lupus erythematosus (SLE).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24554256     DOI: 10.1007/s00393-013-1313-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  38 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.

Authors:  T Witte; T Matthias; F C Arnett; H H Peter; K Hartung; C Sachse; R Wigand; A Braner; J R Kalden; H J Lakomek; R E Schmidt
Journal:  J Rheumatol       Date:  2000-11       Impact factor: 4.666

3.  Prevalence of primary Sjögren's syndrome in an elderly population.

Authors:  A A Drosos; A P Andonopoulos; J S Costopoulos; C S Papadimitriou; H M Moutsopoulos
Journal:  Br J Rheumatol       Date:  1988-04

4.  Linkage studies of HLA and primary Sjögren's syndrome in multicase families.

Authors:  H Foster; A Stephenson; D Walker; G Cavanagh; C Kelly; I Griffiths
Journal:  Arthritis Rheum       Date:  1993-04

5.  Hormone replacement therapy and dry eye syndrome.

Authors:  D A Schaumberg; J E Buring; D A Sullivan; M R Dana
Journal:  JAMA       Date:  2001-11-07       Impact factor: 56.272

6.  Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota.

Authors:  S R Pillemer; E L Matteson; L T Jacobsson; P B Martens; L J Melton; W M O'Fallon; P C Fox
Journal:  Mayo Clin Proc       Date:  2001-06       Impact factor: 7.616

7.  Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.

Authors:  R I Fox; R Dixon; V Guarrasi; S Krubel
Journal:  Lupus       Date:  1996-06       Impact factor: 2.911

8.  Antibodies against alpha-fodrin are associated with sicca syndrome in the general population.

Authors:  Torsten Witte; Torsten Matthias; Janine Bierwirth; Reinhold E Schmidt
Journal:  Ann N Y Acad Sci       Date:  2007-06       Impact factor: 5.691

9.  Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort.

Authors:  Astrid Rasmussen; John A Ice; He Li; Kiely Grundahl; Jennifer A Kelly; Lida Radfar; Donald U Stone; Kimberly S Hefner; Juan-Manuel Anaya; Michael Rohrer; Rajaram Gopalakrishnan; Glen D Houston; David M Lewis; James Chodosh; John B Harley; Pamela Hughes; Jacen S Maier-Moore; Courtney G Montgomery; Nelson L Rhodus; A Darise Farris; Barbara M Segal; Roland Jonsson; Christopher J Lessard; R Hal Scofield; Kathy L Moser Sivils
Journal:  Ann Rheum Dis       Date:  2013-08-22       Impact factor: 19.103

10.  Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry.

Authors:  Jacques-Eric Gottenberg; Gael Cinquetti; Claire Larroche; Bernard Combe; Eric Hachulla; Olivier Meyer; Edouard Pertuiset; Guy Kaplanski; Laurent Chiche; Jean-Marie Berthelot; Bruno Gombert; Philippe Goupille; Christian Marcelli; Séverine Feuillet; Jean Leone; Jean Sibilia; Charles Zarnitsky; Philippe Carli; Stephanie Rist; Philippe Gaudin; Carine Salliot; Muriel Piperno; Adeline Deplas; Maxime Breban; Thierry Lequerre; Pascal Richette; Charles Ghiringhelli; Mohamed Hamidou; Philippe Ravaud; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2012-12-21       Impact factor: 19.103

View more
  2 in total

Review 1.  [Interstitial nephritis in rheumatic diseases].

Authors:  P Korsten; G A Müller
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

2.  Analysis of the first tear film break-up point in Sjögren's syndrome and non-Sjögren's syndrome dry eye patients.

Authors:  Songjiao Zhao; Qihua Le
Journal:  BMC Ophthalmol       Date:  2022-01-03       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.